PARP5A and RNF146 phase separation restrains RIPK1-dependent necroptosis

Shouqiao Hou,Jian Zhang,Xiaoyan Jiang,Yuanxin Yang,Bing Shan,Mengmeng Zhang,Cong Liu,Junying Yuan,Daichao Xu
DOI: https://doi.org/10.1016/j.molcel.2023.12.041
IF: 16
2024-01-26
Molecular Cell
Abstract:Summary Phase separation is a vital mechanism that mediates the formation of biomolecular condensates and their functions. Necroptosis is a lytic form of programmed cell death mediated by RIPK1, RIPK3 , and MLKL downstream of TNFR1 and has been implicated in mediating many human diseases. However, whether necroptosis is regulated by phase separation is not yet known. Here, we show that upon the induction of necroptosis and recruitment by the adaptor protein TAX1BP1, PARP5A and its binding partner RNF146 form liquid-like condensates by multivalent interactions to perform poly ADP-ribosylation (PARylation) and PARylation-dependent ubiquitination (PARdU) of activated RIPK1 in mouse embryonic fibroblasts. We show that PARdU predominantly occurs on the K376 residue of mouse RIPK1, which promotes proteasomal degradation of kinase-activated RIPK1 to restrain necroptosis. Our data demonstrate that PARdU on K376 of mouse RIPK1 provides an alternative cell death checkpoint mediated by phase separation-dependent control of necroptosis by PARP5A and RNF146.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?
The paper primarily explores the mechanism by which PARP5A and RNF146 limit RIPK1-dependent necroptosis through phase separation. Specifically, the research team found that after the activation of necroptosis, PARP5A and RNF146, recruited by TAX1BP1, form liquid-like condensates. This facilitates the Poly ADP-ribosylation (PARylation) and PARylation-dependent ubiquitination (PARdU) of RIPK1. This process mainly occurs at the K376 site of RIPK1 and promotes the degradation of activated RIPK1 via the proteasome pathway, thereby inhibiting the occurrence of necroptosis. The study also mentions that the K376 site of RIPK1 is one of the key sites regulating necroptosis, and the phase separation of PARP5A and RNF146 provides a new perspective for understanding this process. Additionally, TAX1BP1 acts as a bridge between PARP5A, RNF146, and RIPK1, playing an important role in this process. In summary, the paper aims to reveal the new mechanism by which PARP5A, RNF146, and TAX1BP1 regulate RIPK1-dependent necroptosis through phase separation. This research is significant for understanding the regulatory mechanisms of necroptosis and may provide new insights for the treatment of related diseases.